Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Applied Therapeutics Inc (APLT)

Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,927
  • Shares Outstanding, K 144,301
  • Annual Sales, $ 460 K
  • Annual Income, $ -105,620 K
  • EBIT $ -98 M
  • EBITDA $ -97 M
  • 60-Month Beta 1.99
  • Price/Sales 68.79
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.67
  • Most Recent Earnings $-0.13 on 11/13/25
  • Next Earnings Date 04/13/26
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 643.70% (+263.41%)
  • Historical Volatility 404.90%
  • IV Percentile 93%
  • IV Rank 60.06%
  • IV High 986.44% on 07/02/25
  • IV Low 128.39% on 04/25/25
  • Expected Move (DTE 4) 0.3400 (289.86%)
  • Put/Call Vol Ratio 4.18
  • Today's Volume 3,033
  • Volume Avg (30-Day) 903
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 28,666
  • Open Int (30-Day) 33,235
  • Expected Range 0.0000 to 0.4573

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.11
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +62.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1100 +6.64%
on 12/12/25
0.5882 -80.06%
on 11/13/25
-0.7928 (-87.11%)
since 11/12/25
3-Month
0.1100 +6.64%
on 12/12/25
1.5000 -92.18%
on 10/21/25
-0.3033 (-72.11%)
since 09/12/25
52-Week
0.1100 +6.64%
on 12/12/25
1.5000 -92.18%
on 10/21/25
-1.0227 (-89.71%)
since 12/12/24

Most Recent Stories

More News
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger--ALEX, DVS, DXLG, and APLT

NEW YORK , Dec. 12, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars...

ALEX : 20.93 (+0.05%)
DVS : 4.67 (+1.08%)
APLT : 0.1173 (-45.92%)
DXLG : 1.1400 (-26.92%)
APLT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Applied Therapeutics, Inc. is Fair to Shareholders

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

APLT : 0.1173 (-45.92%)
Cycle Pharmaceuticals to Acquire Applied Therapeutics

NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT; “Applied”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare...

APLT : 0.1173 (-45.92%)
Applied Therapeutics Announces Corporate Updates

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for...

APLT : 0.1173 (-45.92%)
Applied Therapeutics Reports Third Quarter 2025 Financial Results 

–   Update on regulatory strategy for govorestat for the treatment of CMT-SORD following receipt of Type C meeting minutes –   Meeting scheduled with the FDA in 4Q 2025 to discuss govorestat...

APLT : 0.1173 (-45.92%)
Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

APLT : 0.1173 (-45.92%)
Applied Therapeutics Provides Update Following Meeting with FDA

NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the Company), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare...

APLT : 0.1173 (-45.92%)
Applied Therapeutics Reports Second Quarter 2025 Financial Results

- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD - Presented full 12-month clinical results and new topline data from INSPIRE...

APLT : 0.1173 (-45.92%)
Applied Therapeutics Announces Key Leadership Appointments

APLT : 0.1173 (-45.92%)
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

APLT : 0.1173 (-45.92%)

Business Summary

Applied Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing drug candidates for unmet medical need. The company's product candidate consists of AT-001, for the treatment of Diabetic Cardiomyopathy; AT-007, for the treatment of Galactosemia and AT-003, for the treatment...

See More

Key Turning Points

3rd Resistance Point 0.1470
2nd Resistance Point 0.1382
1st Resistance Point 0.1277
Last Price 0.1173
1st Support Level 0.1084
2nd Support Level 0.0996
3rd Support Level 0.0891

See More

52-Week High 1.5000
Fibonacci 61.8% 0.9690
Fibonacci 50% 0.8050
Fibonacci 38.2% 0.6410
Last Price 0.1173
52-Week Low 0.1100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar